Loading icon
Press enter or spacebar to select a desired language.
Research
Press enter or spacebar to select a desired language.

PubMed COVID-19 Clinical Care

10251 - 10260 of 44979 results found

Nirmatrelvir/ritonavir for COVID-19: an overview of systematic reviews

Date
Tuesday, December 12, 2023 - 4:00 AM
Description
CONCLUSIONS: There is low to moderate certainty of evidence from SRs that nirmatrelvir/ritonavir reduces mortality, clinical progression and hospitalization rate in COVID-19 patients compared with controls, without increasing the occurrence of

Molybdenum Nanodots for Acute Lung Injury Therapy

Date
Tuesday, December 12, 2023 - 4:00 AM
Description
Acute respiratory disease syndrome (ARDS) is a common critical disease with high morbidity and mortality rates, yet specific and effective treatments for it are currently lacking. ARDS was especially apparent and rampant during the COVID-19 pandemic